{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:22:01Z","timestamp":1792131721930,"version":"4.4.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5R01CA179157"],"award-info":[{"award-number":["5R01CA179157"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.jaad.2018.10.018","type":"journal-article","created":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T11:55:23Z","timestamp":1540209323000},"page":"626-632.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["The prognostic value of inositol polyphosphate 5-phosphatase in cutaneous squamous cell carcinoma"],"prefix":"10.1016","volume":"80","author":[{"given":"Helen J.L.","family":"Cumsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Collin M.","family":"Costello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Butterfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Buras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica E.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Drenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shari A.","family":"Ochoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian L.","family":"Baum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Pittelkow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"DiCaudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandar","family":"Sekulic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron R.","family":"Mangold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jaad.2018.10.018_bib1","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/jamadermatol.2015.1187","article-title":"Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the U.S. population, 2012","volume":"151","author":"Rogers","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2018.10.018_bib2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1067\/mjd.2003.186","article-title":"Skin cancer is among the most costly of all cancers to treat for the Medicare population","volume":"48","author":"Housman","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2018.10.018_bib3","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/jama.294.6.681","article-title":"Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years","volume":"294","author":"Christenson","year":"2005","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.jaad.2018.10.018_bib4","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.mayocp.2017.02.015","article-title":"Incidence and trends of basal cell carcinoma and cutaneous squamous cell carcinoma: a population-based study in Olmsted County, Minnesota, 2000 to 2010","volume":"92","author":"Muzic","year":"2017","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"10.1016\/j.jaad.2018.10.018_bib5","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1805131","article-title":"PD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinoma","volume":"379","author":"Migden","year":"2018","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.jaad.2018.10.018_bib6","doi-asserted-by":"crossref","first-page":"6582","DOI":"10.1158\/1078-0432.CCR-14-1768","article-title":"Mutational landscape of aggressive cutaneous squamous cell carcinoma","volume":"20","author":"Pickering","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.jaad.2018.10.018_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/jamadermatol.2013.6675","article-title":"Staging for cutaneous squamous cell carcinoma as a predictor of sentinel lymph node biopsy results: meta-analysis of American Joint Committee on Cancer criteria and a proposed alternative system","volume":"150","author":"Schmitt","year":"2014","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2018.10.018_bib8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1200\/JCO.2012.48.5326","article-title":"Evaluation of American Joint Committee on Cancer, International Union against Cancer, and Brigham and Women's Hospital tumor staging for cutaneous squamous cell carcinoma","volume":"32","author":"Karia","year":"2014","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.jaad.2018.10.018_bib9","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1001\/jamadermatol.2013.2456","article-title":"Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system","volume":"149","author":"Jambusaria-Pahlajani","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2018.10.018_bib10","series-title":"AJCC Cancer Staging Manual","year":"2010"},{"issue":"4","key":"10.1016\/j.jaad.2018.10.018_bib11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/PAP.0000000000000157","article-title":"Cutaneous squamous cell carcinoma: review of the eighth edition of the American Joint\u00a0Committee on Cancer staging guidelines, prognostic factors, and histopathologic variants","volume":"24","author":"Motaparthi","year":"2017","journal-title":"Adv Anat Pathol"},{"issue":"10","key":"10.1016\/j.jaad.2018.10.018_bib12","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1158\/1940-6207.CAPR-10-0058","article-title":"Loss of inositol polyphosphate 5-phosphatase is an early event in development of cutaneous squamous cell carcinoma","volume":"3","author":"Sekulic","year":"2010","journal-title":"Cancer Prev Res"},{"issue":"1","key":"10.1016\/j.jaad.2018.10.018_bib13","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1111\/jdv.14462","article-title":"Frequent loss of inositol polyphosphate-5-phosphatase in oropharyngeal squamous cell carcinoma","volume":"32","author":"Patel","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"18","key":"10.1016\/j.jaad.2018.10.018_bib14","doi-asserted-by":"crossref","first-page":"4852","DOI":"10.1002\/j.1460-2075.1996.tb00866.x","article-title":"Underexpression of the 43 kDa inositol polyphosphate 5-phosphatase is associated with cellular transformation","volume":"15","author":"Speed","year":"1996","journal-title":"EMBO J"},{"issue":"5-6","key":"10.1016\/j.jaad.2018.10.018_bib15","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.bbalip.2006.04.014","article-title":"Regulation of nuclear processes by inositol polyphosphates","volume":"1761","author":"York","year":"2006","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"10.1016\/j.jaad.2018.10.018_bib16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/gcc.2870070311","article-title":"Deletion mapping of the long arm of chromosome 10 in glioblastoma multiforme","volume":"7","author":"Fults","year":"1993","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"10.1016\/j.jaad.2018.10.018_bib17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s003350010247","article-title":"Cloning, expression and chromosomal location of NKX6B to 10Q26, a region frequently deleted in brain tumors","volume":"12","author":"Lee","year":"2001","journal-title":"Mamm Genome"},{"issue":"10","key":"10.1016\/j.jaad.2018.10.018_bib18","first-page":"1718","article-title":"Inactivation of calcium ion-regulating inositol polyphosphate second messengers is impaired in subpopulations of human leukemia cells","volume":"8","author":"Mengubas","year":"1994","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.jaad.2018.10.018_bib19","doi-asserted-by":"crossref","first-page":"e82108","DOI":"10.1371\/journal.pone.0082108","article-title":"Identification of novel genetic alterations in samples of malignant glioma patients","volume":"8","author":"Milinkovic","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.jaad.2018.10.018_bib20","first-page":"801","article-title":"Impaired degradation of Ca(2+)-regulating second messengers in myeloid leukemia cells. Implications for the regulation of leukemia cell proliferation","volume":"6","author":"Nye","year":"1992","journal-title":"Leukemia"},{"issue":"5A","key":"10.1016\/j.jaad.2018.10.018_bib21","first-page":"3749","article-title":"Inhibition of skin cancer by IP6 in\u00a0vivo: initiation-promotion model","volume":"19","author":"Ishikawa","year":"1999","journal-title":"Anticancer Res"},{"issue":"3","key":"10.1016\/j.jaad.2018.10.018_bib22","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1023\/A:1024078415339","article-title":"Inositol hexaphosphate (IP6) enhances the anti-proliferative effects of adriamycin and tamoxifen in breast cancer","volume":"79","author":"Tantivejkul","year":"2003","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.jaad.2018.10.018_bib23","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1001\/jamadermatol.2015.3781","article-title":"The expression status and prognostic value of cancer stem cell biomarker CD133 in cutaneous squamous cell carcinoma","volume":"152","author":"Xu","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2018.10.018_bib24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/bjd.13226","article-title":"Overexpression of p300 correlates with poor prognosis in patients with cutaneous squamous cell carcinoma","volume":"172","author":"Chen","year":"2015","journal-title":"Br J Dermatol"},{"issue":"6046","key":"10.1016\/j.jaad.2018.10.018_bib25","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1126\/science.1208130","article-title":"The mutational landscape of head and neck squamous cell carcinoma","volume":"333","author":"Stransky","year":"2011","journal-title":"Science"},{"issue":"7536","key":"10.1016\/j.jaad.2018.10.018_bib26","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nature14129","article-title":"Comprehensive genomic characterization of head and neck squamous cell carcinomas","volume":"517","author":"Cancer Genome Atlas Network","year":"2015","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.jaad.2018.10.018_bib27","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1158\/1078-0432.CCR-14-1773","article-title":"Genomic analysis of metastatic cutaneous squamous cell carcinoma","volume":"21","author":"Li","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"10","key":"10.1016\/j.jaad.2018.10.018_bib28","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1177\/0003489414532784","article-title":"Notch1 overexpression associates with poor prognosis in human laryngeal squamous cell carcinoma","volume":"123","author":"Li","year":"2014","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jaad.2018.10.018_bib29","doi-asserted-by":"crossref","first-page":"34081","DOI":"10.1038\/srep34081","article-title":"Expression profiling of cutaneous squamous cell carcinoma with perineural invasion implicates the p53 pathway in the process","volume":"6","author":"Warren","year":"2016","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.jaad.2018.10.018_bib30","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/00000372-199608000-00004","article-title":"Prognostic significance of Ki-67 and p53 immunoreactivity in cutaneous squamous cell carcinomas","volume":"18","author":"Mansoor","year":"1996","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaad.2018.10.018_bib31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jaad.2017.07.031","article-title":"A new evidence-based risk stratification system for cutaneous squamous cell carcinoma into low, intermediate, and high risk groups with implications for management","volume":"78","author":"Baum","year":"2018","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962218327506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962218327506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:48:04Z","timestamp":1759272484000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962218327506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0190962218327506"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2018.10.018","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The prognostic value of inositol polyphosphate 5-phosphatase in cutaneous squamous cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2018.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}